The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2024 | TKI dosage: should clinicians stick to the product monograph recommendations?
Jorge Cortes, MD, Georgia Cancer Center, Augusta, GA, discusses the product monograph dose suggestion for tyrosine kinase inhibitors (TKIs), advising clinicians that they do not need to strictly follow the standard recommendations and should consider patient-specific responses when selecting the appropriate dosage. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
